Net Income (Loss) Attributable to Parent in USD of Predictive Oncology Inc. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Predictive Oncology Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2011 to Q3 2025.
  • Predictive Oncology Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$77.7M, a 2409% decline year-over-year.
  • Predictive Oncology Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$84.3M, a 540% decline year-over-year.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$12.7M, a 9.44% increase from 2023.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$14M, a 45.7% increase from 2022.
  • Predictive Oncology Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$25.7M, a 30.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$84.3M -$77.7M -$74.6M -2409% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$9.78M -$2.07M +$1.11M +34.9% 01 Apr 2025 30 Jun 2025 10-Q 14 Nov 2025
Q1 2025 -$10.9M -$2.44M +$1.78M +42.1% 01 Jan 2025 31 Mar 2025 10-Q 14 Nov 2025
Q4 2024 -$12.7M -$2.17M +$509K +19% 01 Oct 2024 31 Dec 2024 8-K 18 Jul 2025
Q3 2024 -$13.2M -$3.09M +$68.8K +2.17% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$13.2M -$3.18M +$742K +18.9% 01 Apr 2024 30 Jun 2024 10-Q 14 Nov 2025
Q1 2024 -$14M -$4.22M $0 0% 01 Jan 2024 31 Mar 2024 10-Q 14 Nov 2025
Q4 2023 -$14M -$2.68M +$5.24M +66.2% 01 Oct 2023 31 Dec 2023 8-K 18 Jul 2025
Q3 2023 -$19.2M -$3.16M +$896K +22.1% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$20.1M -$3.92M +$6.47M +62.2% 01 Apr 2023 30 Jun 2023 10-Q 12 Nov 2024
Q1 2023 -$26.6M -$4.22M -$848K -25.2% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2025
Q4 2022 -$25.7M -$7.92M -$160K -2.06% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$25.6M -$4.06M +$1.38M +25.4% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$27M -$10.4M -$7.82M -304% 01 Apr 2022 30 Jun 2022 10-Q 13 Nov 2023
Q1 2022 -$19.1M -$3.37M +$518K +13.3% 01 Jan 2022 31 Mar 2022 10-Q 13 Nov 2023
Q4 2021 -$19.7M -$7.76M +$3.71M +32.4% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2023
Q3 2021 -$23.4M -$5.44M +$870K +13.8% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$24.2M -$2.57M +$1M +28.1% 01 Apr 2021 30 Jun 2021 10-Q 10 Nov 2022
Q1 2021 -$25.2M -$3.89M +$641K +14.1% 01 Jan 2021 31 Mar 2021 10-Q 10 Nov 2022
Q4 2020 -$25.9M -$11.5M +$2.08M +15.4% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 -$28M -$6.31M -$2.3M -57.4% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$25.7M -$3.58M -$5.04M -344% 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$20.6M -$4.53M -$1.24M -37.5% 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021
Q4 2019 -$19.4M -$13.6M 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 -$4.01M -$1.5M -59.9% 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $1.47M +$3.84M 01 Apr 2019 30 Jun 2019 10-Q 16 Nov 2020
Q1 2019 -$3.29M 01 Jan 2019 31 Mar 2019 10-Q 16 Nov 2020
Q3 2018 -$2.51M 01 Jul 2018 30 Sep 2018 10-Q 15 Nov 2019
Q2 2018 -$2.37M 01 Apr 2018 30 Jun 2018 10-Q 19 Aug 2019
Q2 2015 -$4.89M -$1.19M +$551K +31.7% 01 Apr 2015 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 -$5.44M -$226K +$1.39M +86% 01 Jan 2015 31 Mar 2015 10-Q 18 May 2015
Q4 2014 -$6.83M -$2.37M -$211K -9.8% 01 Oct 2014 31 Dec 2014 10-K 30 Apr 2015
Q3 2014 -$6.62M -$1.12M +$2.86M +71.9% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 -$9.48M -$1.74M -$560K -47.7% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 -$8.92M -$1.62M +$485K +23.1% 01 Jan 2014 31 Mar 2014 10-Q 18 May 2015
Q4 2013 -$9.41M -$2.15M -$437K -25.4% 01 Oct 2013 31 Dec 2013 10-K 30 Apr 2015
Q3 2013 -$8.97M -$3.97M -$1.12M -39.2% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014
Q2 2013 -$7.85M -$1.18M +$960K +45% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$8.81M -$2.1M -$1.39M -195% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 -$7.42M -$1.72M 01 Oct 2012 31 Dec 2012 10-K 27 Mar 2014
Q3 2012 -$2.86M -$2.2M -337% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$2.14M -$1.75M -450% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$713K 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q3 2011 -$654K 01 Jul 2011 30 Sep 2011 10-Q 15 Nov 2012
Q2 2011 -$388K 01 Apr 2011 30 Jun 2011 10-Q/A 24 Aug 2012

Predictive Oncology Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$12.7M +$1.32M +9.44% 01 Jan 2024 31 Dec 2024 8-K 18 Jul 2025
2023 -$14M +$11.8M +45.7% 01 Jan 2023 31 Dec 2023 8-K 18 Jul 2025
2022 -$25.7M -$6.08M -30.9% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$19.7M +$6.23M +24.1% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023
2020 -$25.9M -$6.49M -33.5% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 -$19.4M -$9.3M -92.2% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 -$10.1M 01 Jan 2018 31 Dec 2018 10-K 01 Apr 2020
2014 -$6.83M +$2.57M +27.4% 01 Jan 2014 31 Dec 2014 10-K 30 Apr 2015
2013 -$9.41M -$1.98M -26.7% 01 Jan 2013 31 Dec 2013 10-K 30 Apr 2015
2012 -$7.42M -$2.94M -65.4% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014
2011 -$4.49M 01 Jan 2011 31 Dec 2011 10-K 22 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.